# An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

> **NCT02756832** · — · COMPLETED · sponsor: **Takeda** · enrollment: 1409 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Alogliptin Benzoate

## Key facts

- **NCT ID:** NCT02756832
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-20
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-04-28
- **Target enrollment:** 1409 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02756832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02756832, "An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02756832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*